✦ LIBER ✦

Adjuvant CMF +/− tamoxifen (TAM) in premenopausal high-risk patients (PHRPs) with early breast cancer

✍ Scribed by M. Andersson; C. Kamby; C. Rose; J. Andersen; M.-B. Jensen; H.T. Mouridsen

Book ID: 117666269
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 133 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80149-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adjuvant endocrine treatme

Comparison of adjuvant endocrine treatment (tamoxifen and goserelin) vs. chemotherapy (CMF) in premenopausal patients with hormone-responsive early breast cancer: Results from the Austrian Breast Cancer Study Group (ABCSG)

✍ E. Kubista; M. Seifert; M. Gnant; R. Jakesz 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Adjuvant therapy for operable breast can

Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients

✍ Pannuti, F.; Martoni, A.; Cilenti, G.; Camaggi, C.M.; Fruet, F. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 646 KB

2050 POSTER Endocrine effects of adjuvan

2050 POSTER Endocrine effects of adjuvant letrozole plus triptoreline versus tamoxifen plus triptoreline in premenopausal patients with early breast cancer

✍ E. Rossi; F. Perrone; G. Esposito; G. Landi; F. Di Rella; R. Thomas; C. Gallo; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Postoperative Radiotherapy in High-Risk

Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy

✍ Overgaard, Marie; Hansen, Per S.; Overgaard, Jens; Rose, Carsten; Andersson, Mic 📂 Article 📅 1997 🏛 Massachusetts Medical Society 🌐 English ⚖ 149 KB

2–59 High Progesterone Receptor Expressi

2–59 High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients

✍ Elledge, R.M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Adjuvant anthracycline in breast cancer.

Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF Combination with epirubicin

✍ Henning T. Mouridsen; Jørn Andersen; Michael Andersson; Per Dombernowsky; Bent E 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 118 KB